The global liquid handling system market size was estimated at USD 4,910.0 million in 2025 and is projected to reach USD 9,000.3 million by 2033, grow at a CAGR of 8.0% from 2026 to 2033. This consistent growth reflects the increasing importance of precision, efficiency, and automation in laboratory environments. Liquid handling systems are essential tools in modern laboratories, enabling accurate measurement, transfer, and mixing of liquids across a wide range of applications. As scientific research becomes more complex and data-driven, the demand for advanced liquid handling technologies continues to rise.
A key factor driving this growth is the rapid expansion of pharmaceutical and biotechnology research. These industries are heavily reliant on precise liquid handling for processes such as drug formulation, sample preparation, and biological analysis. As the need for new therapies and innovative treatments increases, laboratories are under pressure to enhance productivity and maintain high levels of accuracy, making advanced liquid handling systems indispensable.
The growing intensity of drug discovery activities is further accelerating adoption. Modern drug development involves screening large numbers of compounds and conducting complex experiments, which require highly efficient and reliable liquid handling solutions. High-throughput screening techniques, in particular, depend on automated systems that can process thousands of samples quickly and consistently. This has led to a significant shift from manual pipetting methods to automated platforms that can handle large volumes of work with greater speed and precision.
In addition, rising investments in research and development are encouraging laboratories to upgrade their equipment and adopt state-of-the-art technologies. Automation plays a critical role in this transformation by reducing the likelihood of human error and ensuring consistent results across experiments. This is especially important in complex research settings where even minor inaccuracies can impact outcomes. By improving reproducibility and reliability, automated liquid handling systems are helping researchers achieve more accurate and dependable results, ultimately supporting advancements in science and healthcare.
North America led the global liquid handling system sector, accounting for the largest revenue share of 43.1% in 2025. This strong regional dominance is largely driven by the presence of advanced healthcare infrastructure, a well-established pharmaceutical and biotechnology industry, and significant investments in research and development. The region is home to many leading research institutions, contract research organizations, and life sciences companies that rely heavily on advanced laboratory automation technologies. Additionally, the increasing focus on precision medicine, biologics, and high-throughput research has further accelerated the adoption of liquid handling systems across North America.
Within the region, the liquid handling system industry in the United States accounted for the largest share of revenue in 2025. This can be attributed to the country’s leadership in pharmaceutical innovation, strong funding support for biomedical research, and the presence of major industry players. The U.S. continues to invest heavily in drug discovery, clinical research, and advanced therapeutic development, all of which require highly accurate and efficient liquid handling solutions. Furthermore, the growing adoption of laboratory automation in academic, clinical, and industrial settings is reinforcing the country’s leading position.
Based on type, the automated liquid handling segment is expected to register the fastest CAGR of 8.4% from 2026 to 2033. This growth is driven by the increasing need for high precision, reproducibility, and efficiency in laboratory workflows. Automated systems significantly reduce manual intervention, minimize human error, and enable the processing of large volumes of samples in a shorter time frame. As laboratories continue to scale up operations and handle more complex experiments, the shift toward automation is becoming essential for maintaining accuracy and productivity.
In terms of product, the workstations segment is projected to grow at the fastest CAGR of 8.6% from 2026 to 2033. Liquid handling workstations integrate multiple functions, such as dispensing, mixing, and sample preparation, into a single automated platform. This integration enhances workflow efficiency and reduces the need for multiple standalone instruments. Workstations are particularly valuable in high-throughput environments, where streamlined processes and consistent results are critical. Their ability to support a wide range of applications makes them increasingly popular among research laboratories and industrial users.
From an application perspective, the cell and gene therapy manufacturing segment is expected to grow at the fastest CAGR of 8.7% from 2026 to 2033. The rapid advancement of cell and gene therapies, which require highly precise and sterile handling of biological samples, is driving the demand for advanced liquid handling systems. These therapies involve complex production processes where accuracy and reproducibility are critical to ensure safety and efficacy. As the adoption of personalized medicine and advanced biologics continues to expand, the need for reliable and automated liquid handling solutions in this segment is expected to increase significantly.
Looking for more specific insights? Customize this report to suite your business needs
Some of the key players operating in the liquid handling system sector include Thermo Fisher Scientific Inc., Danaher Corporation, and PerkinElmer. These companies are actively contributing to technological advancements and expanding their product portfolios to meet the growing demand for efficient, precise, and automated laboratory solutions across pharmaceutical, biotechnology, and research applications.
Thermo Fisher Scientific Inc. plays a significant role in the liquid handling systems industry through its comprehensive portfolio of manual, electronic, and automated solutions. The company offers a wide range of instruments designed to support critical laboratory processes, particularly in drug discovery and clinical diagnostics. Its integrated liquid-handling workstations are built to streamline complex workflows, enabling laboratories to improve productivity while maintaining high levels of accuracy. Thermo Fisher places strong emphasis on automation, software integration, and workflow optimization, ensuring that its systems can seamlessly fit into modern laboratory environments. In addition, the company’s extensive consumables portfolio—such as pipette tips, reagents, and other lab essentials—drives consistent, recurring demand from end users. Its deep and well-established presence in pharmaceutical and biotechnology laboratories further strengthens its competitive position and reinforces its leadership in the industry.
Danaher Corporation is another key participant in the market, primarily through its Beckman Coulter Life Sciences business segment. The company addresses the growing need for automated and semi-automated liquid handling solutions, particularly in areas such as genomics, diagnostics, and life sciences research. Danaher focuses on delivering systems that ensure high levels of precision, reproducibility, and scalability, which are essential for laboratories operating in regulated environments. Its platforms are designed to handle high-volume and complex workflows, making them suitable for large-scale research and clinical applications. Furthermore, the company continues to invest in product innovation and technological enhancements, enabling it to adapt to evolving industry requirements and maintain a strong competitive edge in the liquid handling systems space.
Looking for a report customized to your requirements? Explore our Custom Research Offering
Grand View Research offers
√ Focused market intelligence reports on specific geographies or high-growth segments.
√ Extended forecast timelines for long-term planning.
√ Competitor Benchmarking and Supply Chain Analysis
√ Inclusion of regulatory and policy assessments.
√ Inclusion of custom data models, KPIs, or applications unique to your business
√ Specific high-impact Data Decks and Tables to support effective decision making
And much more…
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc.
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
Email: sales@grandviewresearch.com
Explore Our Services: https://www.grandviewresearch.com/services/brainshare
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Tiếng Việt